Symbols / HKPD Stock $0.67 +4.36% Cellyan Biotechnology Co., Ltd
HKPD (Stock) Chart
Stock Fundamentals
|
|
|
|
|
|
About
Cellyan Biotechnology Co., Ltd, an investment holding company, engages in the over the counter (OTC) pharmaceutical business in Hong Kong and Mainland China. The company provides OTC pharmaceutical cross-border procurement and distribution and e-commerce supply chain services. It also offers custom clearance, drugs enlisting, warehouse, and other logistics services. The company serves e-commerce platform logistics partners, merchants, and pharmaceutical distributors. The company was formerly known as Hong Kong Pharma Digital Technology Holdings Limited and changed its name to Cellyan Biotechnology Co., Ltd in December 2025. Cellyan Biotechnology Co., Ltd was incorporated in 2023 and is based in Yau Tong, Hong Kong.
Ratings
- Insiders Who Purchased US$6.90m Of Hong Kong Pharma Digital Technology Holdings Stock May Not Have Expected 19% Tumble - simplywall.st Wed, 03 Dec 2025 08
- HKPD (Cellyan) records 21.7 percent year over year Q2 2025 revenue growth, shares hold steady. - EBITDA - Cổng thông tin điện tử Tỉnh Sơn La hu, 23 Apr 2026 11
- HKPD (Cellyan) records 21.7 percent year over year Q2 2025 revenue growth, shares hold steady. - Senior Analyst Forecasts - Cổng thông tin điện tử tỉnh Tây Ninh Wed, 22 Apr 2026 23
- HKPD (Cellyan) posts 21.7 percent Q2 2025 revenue growth, shares drop 6.58 percent amid negative earnings. - Elite Trading Signals - UBND thành phố Hải Phòng hu, 23 Apr 2026 09
- Cellyan Biotechnology (HKPD) completes $6.5M private unit financing - Stock Titan hu, 26 Mar 2026 07
- HKPD (Cellyan) posts 21.7 percent Q2 2025 revenue growth, shares drop 6.58 percent amid negative earnings. - Buyback Authorization - Cổng thông tin điện tử Tỉnh Sơn La hu, 23 Apr 2026 07
- How Is HKPD Stock Performing? - StocksToTrade ue, 26 Aug 2025 07
- Cellyan Biotechnology Reports Lower Revenue and Profit in Latest Interim Results - TipRanks Wed, 18 Mar 2026 07
- 12.5M shares for resale — Cellyan Biotechnology (NASDAQ: HKPD) - Stock Titan Fri, 27 Mar 2026 07
- HKPD Stock Analysis: Cellyan Biotechnology Co. Ltd gains 1.59% to trade at 0.57 dollar - UBND thành phố Hải Phòng Fri, 03 Apr 2026 07
- Cellyan (HKPD) Stock: Is It Ready for Entry (Institutional Demand) 2026-04-18 - Community Volume Signals - Cổng thông tin điện tử Tỉnh Sơn La Sat, 18 Apr 2026 23
- HKPD Stock Price and Chart — NASDAQ:HKPD - TradingView Wed, 15 Jan 2025 18
- symbol__ Stock Quote Price and Forecast - CNN Fri, 24 Jan 2025 06
- Cellyan Biotechnology (NASDAQ: HKPD) warned on bid price rule compliance - Stock Titan Fri, 16 Jan 2026 08
- HKPD IPO News - Pharma services provider Hong Kong Pharma Digital Technology prices US IPO at the $4 low end - renaissancecapital.com ue, 14 Jan 2025 08
Insider Transactions
No recent insider transactions.
Financials
| Line Item | Trend | 2025-03-31 | 2024-03-31 | 2023-03-31 |
|---|---|---|---|---|
| Total Revenue |
|
20.31
+21.72%
|
16.69
+32.91%
|
12.56
|
| Operating Revenue |
|
20.31
+21.72%
|
16.69
+32.91%
|
12.56
|
| Cost Of Revenue |
|
17.90
+36.32%
|
13.13
+33.74%
|
9.82
|
| Reconciled Cost Of Revenue |
|
17.90
+36.32%
|
13.13
+33.74%
|
9.82
|
| Gross Profit |
|
2.42
-32.13%
|
3.56
+29.93%
|
2.74
|
| Operating Expense |
|
2.21
+17.45%
|
1.89
+13.45%
|
1.66
|
| Selling General And Administration |
|
2.22
+17.28%
|
1.89
+7.47%
|
1.76
|
| Other Operating Expenses |
|
-0.00
+63.69%
|
-0.00
+95.80%
|
-0.10
|
| Total Expenses |
|
20.11
+33.95%
|
15.02
+30.81%
|
11.48
|
| Operating Income |
|
0.20
-88.00%
|
1.67
+55.35%
|
1.08
|
| Total Operating Income As Reported |
|
0.13
-91.79%
|
1.61
+54.08%
|
1.04
|
| EBITDA |
|
1.21
-52.37%
|
2.53
+44.11%
|
1.76
|
| Normalized EBITDA |
|
1.27
-51.27%
|
2.60
+45.09%
|
1.79
|
| Reconciled Depreciation |
|
1.07
+15.97%
|
0.93
+29.53%
|
0.71
|
| EBIT |
|
0.13
-91.68%
|
1.61
+54.09%
|
1.04
|
| Total Unusual Items |
|
-0.06
+6.89%
|
-0.06
-100.12%
|
-0.03
|
| Total Unusual Items Excluding Goodwill |
|
-0.06
+6.89%
|
-0.06
-100.12%
|
-0.03
|
| Special Income Charges |
|
-0.01
-1162.99%
|
0.00
|
0.00
|
| Net Income |
|
-0.03
-102.03%
|
1.33
+33.21%
|
1.00
|
| Pretax Income |
|
0.04
-97.63%
|
1.53
+49.49%
|
1.02
|
| Net Non Operating Interest Income Expense |
|
-0.10
-16.57%
|
-0.08
-257.43%
|
-0.02
|
| Interest Expense Non Operating |
|
0.10
+18.00%
|
0.08
+256.11%
|
0.02
|
| Net Interest Income |
|
-0.10
-16.57%
|
-0.08
-257.43%
|
-0.02
|
| Interest Expense |
|
0.10
+18.00%
|
0.08
+256.11%
|
0.02
|
| Interest Income Non Operating |
|
0.00
+267.30%
|
0.00
+116.44%
|
0.00
|
| Interest Income |
|
0.00
+267.30%
|
0.00
+116.44%
|
0.00
|
| Other Income Expense |
|
-0.07
-5.76%
|
-0.06
-95.27%
|
-0.03
|
| Other Non Operating Income Expenses |
|
-0.01
-325.75%
|
-0.00
-21.02%
|
-0.00
|
| Gain On Sale Of Security |
|
-0.05
+19.83%
|
-0.06
-102.38%
|
-0.03
|
| Gain On Sale Of Business |
|
0.00
-100.00%
|
0.01
|
0.00
|
| Tax Provision |
|
0.06
-67.81%
|
0.20
+769.37%
|
0.02
|
| Tax Rate For Calcs |
|
0.00
+28.91%
|
0.00
+481.82%
|
0.00
|
| Tax Effect Of Unusual Items |
|
-0.01
-20.03%
|
-0.01
-1064.33%
|
-0.00
|
| Net Income Including Noncontrolling Interests |
|
-0.03
-102.03%
|
1.33
+33.21%
|
1.00
|
| Net Income From Continuing Operation Net Minority Interest |
|
-0.03
-102.03%
|
1.33
+33.21%
|
1.00
|
| Net Income From Continuing And Discontinued Operation |
|
-0.03
-102.03%
|
1.33
+33.21%
|
1.00
|
| Net Income Continuous Operations |
|
-0.03
-102.03%
|
1.33
+33.21%
|
1.00
|
| Minority Interests |
|
—
|
0.00
|
0.00
|
| Normalized Income |
|
0.02
-98.44%
|
1.38
+34.55%
|
1.03
|
| Net Income Common Stockholders |
|
-0.03
-102.03%
|
1.33
+33.21%
|
1.00
|
| Diluted EPS |
|
-0.00
-102.48%
|
0.12
+33.21%
|
0.09
|
| Basic EPS |
|
-0.00
-102.48%
|
0.12
+33.21%
|
0.09
|
| Basic Average Shares |
|
10.21
-7.22%
|
11.00
+0.00%
|
11.00
|
| Diluted Average Shares |
|
10.21
-7.22%
|
11.00
+0.00%
|
11.00
|
| Diluted NI Availto Com Stockholders |
|
-0.03
-102.03%
|
1.33
+33.21%
|
1.00
|
| Gain On Sale Of PPE |
|
-0.01
+30.64%
|
-0.01
|
0.00
|
| Line Item | Trend | 2025-03-31 | 2024-03-31 | 2023-03-31 |
|---|---|---|---|---|
| Total Assets |
|
9.42
+8.65%
|
8.67
+154.41%
|
3.41
|
| Current Assets |
|
8.73
+11.86%
|
7.80
+183.86%
|
2.75
|
| Cash Cash Equivalents And Short Term Investments |
|
3.01
+385.10%
|
0.62
+18.10%
|
0.52
|
| Cash And Cash Equivalents |
|
0.75
+20.84%
|
0.62
+18.10%
|
0.52
|
| Cash Financial |
|
0.75
+20.84%
|
0.62
+18.10%
|
0.52
|
| Other Short Term Investments |
|
2.26
|
0.00
|
—
|
| Receivables |
|
4.71
+26.74%
|
3.72
+114.90%
|
1.73
|
| Accounts Receivable |
|
4.66
+25.88%
|
3.70
+124.64%
|
1.65
|
| Gross Accounts Receivable |
|
4.66
+25.88%
|
3.70
+124.64%
|
1.65
|
| Allowance For Doubtful Accounts Receivable |
|
0.00
|
0.00
|
0.00
|
| Other Receivables |
|
—
|
—
|
0.24
|
| Inventory |
|
0.56
-40.00%
|
0.93
+388.93%
|
0.19
|
| Raw Materials |
|
0.04
-24.20%
|
0.05
-18.31%
|
0.07
|
| Finished Goods |
|
0.52
-40.97%
|
0.88
+603.92%
|
0.12
|
| Prepaid Assets |
|
0.45
-64.52%
|
1.26
+317.23%
|
0.30
|
| Current Deferred Assets |
|
0.00
-100.00%
|
1.26
|
0.00
|
| Restricted Cash |
|
0.00
-94.79%
|
0.01
|
0.00
|
| Total Non Current Assets |
|
0.69
-20.26%
|
0.87
+31.48%
|
0.66
|
| Net PPE |
|
0.59
-28.78%
|
0.83
+27.43%
|
0.65
|
| Gross PPE |
|
0.74
-20.15%
|
0.92
+30.96%
|
0.70
|
| Accumulated Depreciation |
|
-0.14
-62.01%
|
-0.09
-77.92%
|
-0.05
|
| Properties |
|
0.00
|
0.00
|
0.00
|
| Machinery Furniture Equipment |
|
0.02
+0.60%
|
0.02
-77.71%
|
0.08
|
| Other Properties |
|
0.65
-23.94%
|
0.86
+42.59%
|
0.60
|
| Leases |
|
0.07
+39.04%
|
0.05
+96.02%
|
0.02
|
| Goodwill And Other Intangible Assets |
|
0.10
+203.02%
|
0.03
+689.90%
|
0.00
|
| Other Intangible Assets |
|
0.10
+203.02%
|
0.03
+689.90%
|
0.00
|
| Total Liabilities Net Minority Interest |
|
4.43
+0.32%
|
4.41
+56.43%
|
2.82
|
| Current Liabilities |
|
2.92
-8.16%
|
3.18
+24.56%
|
2.55
|
| Payables And Accrued Expenses |
|
1.93
-9.72%
|
2.14
+14.67%
|
1.86
|
| Payables |
|
1.90
-9.46%
|
2.10
+16.99%
|
1.80
|
| Accounts Payable |
|
1.73
+30.58%
|
1.32
-5.53%
|
1.40
|
| Other Payable |
|
0.07
+16.23%
|
0.06
-28.26%
|
0.08
|
| Current Accrued Expenses |
|
0.03
-25.80%
|
0.03
-48.66%
|
0.07
|
| Total Tax Payable |
|
0.11
-51.99%
|
0.22
+870.73%
|
0.02
|
| Current Debt And Capital Lease Obligation |
|
0.86
+1.76%
|
0.85
+102.49%
|
0.42
|
| Current Debt |
|
0.37
+72.66%
|
0.22
+245.13%
|
0.06
|
| Other Current Borrowings |
|
0.37
+105.86%
|
0.18
+189.47%
|
0.06
|
| Current Capital Lease Obligation |
|
0.49
-22.29%
|
0.63
+77.60%
|
0.36
|
| Current Deferred Liabilities |
|
0.12
-34.84%
|
0.19
-28.71%
|
0.27
|
| Current Deferred Revenue |
|
0.12
-34.84%
|
0.19
-28.71%
|
0.27
|
| Total Non Current Liabilities Net Minority Interest |
|
1.51
+22.08%
|
1.24
+355.74%
|
0.27
|
| Long Term Debt And Capital Lease Obligation |
|
1.51
+22.08%
|
1.24
+355.74%
|
0.27
|
| Long Term Debt |
|
1.50
+34.35%
|
1.12
+857.78%
|
0.12
|
| Long Term Capital Lease Obligation |
|
0.01
-94.56%
|
0.12
-23.78%
|
0.15
|
| Stockholders Equity |
|
4.99
+17.31%
|
4.25
+626.82%
|
0.59
|
| Common Stock Equity |
|
4.99
+17.31%
|
4.25
+626.82%
|
0.59
|
| Capital Stock |
|
0.01
+10.00%
|
0.01
+46.13%
|
0.01
|
| Common Stock |
|
0.01
+10.00%
|
0.01
+46.13%
|
0.01
|
| Share Issued |
|
11.00
+0.00%
|
11.00
+0.00%
|
11.00
|
| Ordinary Shares Number |
|
11.00
+0.00%
|
11.00
+0.00%
|
11.00
|
| Additional Paid In Capital |
|
3.46
+14.80%
|
3.02
+677.30%
|
0.39
|
| Retained Earnings |
|
1.50
-1.77%
|
1.53
+660.27%
|
0.20
|
| Gains Losses Not Affecting Retained Earnings |
|
0.01
+322.70%
|
-0.00
-11.88%
|
-0.00
|
| Other Equity Adjustments |
|
0.01
+322.70%
|
-0.00
-11.88%
|
-0.00
|
| Total Equity Gross Minority Interest |
|
4.99
+17.31%
|
4.25
+626.82%
|
0.59
|
| Total Capitalization |
|
6.49
+20.86%
|
5.37
+665.26%
|
0.70
|
| Working Capital |
|
5.81
+25.61%
|
4.63
+2231.23%
|
0.20
|
| Invested Capital |
|
6.87
+22.85%
|
5.59
+630.99%
|
0.76
|
| Total Debt |
|
2.37
+13.80%
|
2.09
+201.97%
|
0.69
|
| Net Debt |
|
1.13
+57.59%
|
0.71
|
—
|
| Capital Lease Obligations |
|
0.50
-33.61%
|
0.75
+46.98%
|
0.51
|
| Net Tangible Assets |
|
4.89
+15.91%
|
4.22
+626.38%
|
0.58
|
| Tangible Book Value |
|
4.89
+15.91%
|
4.22
+626.38%
|
0.58
|
| Duefrom Related Parties Current |
|
0.06
+186.96%
|
0.02
-76.20%
|
0.08
|
| Dueto Related Parties Current |
|
0.00
-99.74%
|
0.50
+72.16%
|
0.29
|
| Inventories Adjustments Allowances |
|
0.00
|
0.00
|
0.00
|
| Line Of Credit |
|
0.00
-100.00%
|
0.03
|
0.00
|
| Other Equity Interest |
|
—
|
-0.30
-4284.04%
|
-0.01
|
| Line Item | Trend | 2025-03-31 | 2024-03-31 | 2023-03-31 |
|---|---|---|---|---|
| Operating Cash Flow |
|
0.57
+244.35%
|
-0.39
-122.83%
|
1.73
|
| Cash Flow From Continuing Operating Activities |
|
0.57
+244.35%
|
-0.39
-122.83%
|
1.73
|
| Net Income From Continuing Operations |
|
-0.03
-102.03%
|
1.33
+33.21%
|
1.00
|
| Depreciation Amortization Depletion |
|
1.07
+15.97%
|
0.93
+29.53%
|
0.71
|
| Depreciation |
|
1.07
+15.97%
|
0.93
+29.53%
|
0.71
|
| Depreciation And Amortization |
|
1.07
+15.97%
|
0.93
+29.53%
|
0.71
|
| Operating Gains Losses |
|
0.04
+6193.93%
|
-0.00
|
—
|
| Gain Loss On Investment Securities |
|
0.04
|
—
|
—
|
| Gain Loss On Sale Of PPE |
|
0.00
-100.00%
|
0.01
|
0.00
|
| Change In Working Capital |
|
-0.52
+80.36%
|
-2.65
-18627.77%
|
0.01
|
| Change In Receivables |
|
-1.02
+51.38%
|
-2.09
-88.45%
|
-1.11
|
| Changes In Account Receivables |
|
-0.92
+55.13%
|
-2.05
-120.28%
|
-0.93
|
| Change In Inventory |
|
0.38
+150.97%
|
-0.74
-288.14%
|
-0.19
|
| Change In Prepaid Assets |
|
—
|
—
|
-0.18
|
| Change In Payables And Accrued Expense |
|
0.28
+209.79%
|
0.09
-90.69%
|
0.98
|
| Change In Payable |
|
0.28
+209.79%
|
0.09
-90.69%
|
0.98
|
| Change In Account Payable |
|
0.40
+477.19%
|
-0.11
-111.01%
|
0.96
|
| Change In Other Working Capital |
|
-0.16
-274.64%
|
0.09
-72.27%
|
0.34
|
| Investing Cash Flow |
|
-2.45
-5917.66%
|
-0.04
+69.12%
|
-0.13
|
| Cash Flow From Continuing Investing Activities |
|
-2.45
-5917.66%
|
-0.04
+69.12%
|
-0.13
|
| Net PPE Purchase And Sale |
|
-0.07
-258.41%
|
-0.02
+82.98%
|
-0.11
|
| Purchase Of PPE |
|
-0.07
-32.58%
|
-0.05
+54.00%
|
-0.11
|
| Sale Of PPE |
|
0.00
-100.00%
|
0.03
|
0.00
|
| Capital Expenditure |
|
-0.15
-76.09%
|
-0.09
+25.22%
|
-0.12
|
| Net Investment Purchase And Sale |
|
-2.30
|
0.00
|
0.00
|
| Purchase Of Investment |
|
-2.30
|
0.00
|
0.00
|
| Gain Loss On Sale Of Business |
|
0.00
+100.00%
|
-0.01
|
0.00
|
| Net Intangibles Purchase And Sale |
|
-0.09
-141.12%
|
-0.04
-1052.25%
|
-0.00
|
| Purchase Of Intangibles |
|
-0.09
-141.12%
|
-0.04
-1052.25%
|
-0.00
|
| Net Other Investing Changes |
|
—
|
0.01
+197.24%
|
-0.01
|
| Financing Cash Flow |
|
2.00
+271.31%
|
0.54
+146.49%
|
-1.16
|
| Cash Flow From Continuing Financing Activities |
|
2.00
+271.31%
|
0.54
+146.49%
|
-1.16
|
| Net Issuance Payments Of Debt |
|
-0.93
-348.59%
|
0.37
+132.28%
|
-1.16
|
| Issuance Of Debt |
|
1.59
-25.83%
|
2.14
+1032.32%
|
0.19
|
| Repayment Of Debt |
|
-2.52
-42.22%
|
-1.77
-31.57%
|
-1.34
|
| Long Term Debt Issuance |
|
1.59
-25.83%
|
2.14
+1032.32%
|
0.19
|
| Long Term Debt Payments |
|
-2.52
-42.22%
|
-1.77
-31.57%
|
-1.34
|
| Net Long Term Debt Issuance |
|
-0.93
-348.59%
|
0.37
+132.28%
|
-1.16
|
| Net Common Stock Issuance |
|
4.30
+743.96%
|
0.51
|
0.00
|
| Net Other Financing Charges |
|
-1.38
-299.05%
|
-0.35
|
—
|
| Changes In Cash |
|
0.11
+7.02%
|
0.10
-76.74%
|
0.44
|
| Effect Of Exchange Rate Changes |
|
0.01
+2647.03%
|
0.00
+41.74%
|
0.00
|
| Beginning Cash Position |
|
0.63
+19.57%
|
0.52
+517.34%
|
0.08
|
| End Cash Position |
|
0.75
+19.43%
|
0.63
+19.57%
|
0.52
|
| Free Cash Flow |
|
0.41
+185.88%
|
-0.48
-129.97%
|
1.61
|
| Interest Paid Supplemental Data |
|
0.10
+18.00%
|
0.08
+44.38%
|
0.06
|
| Income Tax Paid Supplemental Data |
|
0.29
|
0.00
|
0.00
|
| Change In Income Tax Payable |
|
-0.11
-158.53%
|
0.20
+769.37%
|
0.02
|
| Change In Tax Payable |
|
-0.11
-158.53%
|
0.20
+769.37%
|
0.02
|
| Common Stock Issuance |
|
4.30
+743.96%
|
0.51
|
0.00
|
| Issuance Of Capital Stock |
|
4.30
+743.96%
|
0.51
|
0.00
|
SEC Filings
No SEC filings found for this symbol (may be non-US or ticker not in SEC index).
Trades
| Date | User | Broker | Pattern | Type | Position Size | Entry Price | Trade P&L | Status |
|---|
Posts
| Published | Title | Author | Category |
|---|